A multicenter trial facilitated by the American College of Radiology Imaging Network will evaluate the value of FDG PET/CT in staging of N0 neck patients -- those with head and neck cancer that does not seem to have metastasized to the lymph nodes. About 15 sites will be participating in the two-year study, which will have 292 subjects.

Related Summaries